132 related articles for article (PubMed ID: 2838706)
1. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
[TBL] [Abstract][Full Text] [Related]
2. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
[TBL] [Abstract][Full Text] [Related]
3. The opioid kappa-selective compound U-50,488H does not inhibit intestinal propulsion in rats.
Tavani A; Gambino MC; Petrillo P
J Pharm Pharmacol; 1984 May; 36(5):343-4. PubMed ID: 6145777
[TBL] [Abstract][Full Text] [Related]
4. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
5. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
6. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
7. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
8. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Laorden ML; Milanés MV
J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
[TBL] [Abstract][Full Text] [Related]
9. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective opioid agonists on feline colonic transit.
Krevsky B; Cowan A; Maurer AH; Butt W; Fisher RS
Life Sci; 1991; 48(16):1597-602. PubMed ID: 1850059
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
13. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
Garaulet JV; Milanés MV; Laorden ML
J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of mu agonists by U50,488H in the rat.
Porreca F; Tortella FC
Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
[TBL] [Abstract][Full Text] [Related]
15. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
16. The mu, kappa and delta properties of various opioid agonists.
Takemori AE; Ikeda M; Portoghese PS
Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
Attali B; Vogel Z
Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
[TBL] [Abstract][Full Text] [Related]
19. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
Sheldon RJ; Nunan L; Porreca F
Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
[TBL] [Abstract][Full Text] [Related]
20. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]